Repligen Logo

Repligen

🇺🇸
RGEN
US7599161095

Repligen is a leading US-based company providing innovative bioprocessing technologies for biopharmaceutical development and manufacturing. Specializing in filtration, chromatography, and cell culture media, Repligen delivers essential solutions and single-use systems for global life sciences. The company supports increased efficiency in biopharmaceutical production.

Next Quarterly Earnings

Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days

Stock Price

All Dates

Company Information

Name
Repligen
Ticker Symbol
RGEN
ISIN
US7599161095
Country
🇺🇸
USA
More Financial Information